Results 111 to 120 of about 14,448,012 (256)

Hydrogels Augmented With Artificial Sweeteners can Inhibit Multidrug‐Resistant Acinetobacter baumannii Growth and Biofilm Formation While Demonstrating Safety in Pre‐Clinical Pilot Human Trials

Advanced Healthcare Materials, EarlyView.
Using PVA–borax hydrogels as carriers for off‐the‐shelf artificial sweeteners to fight multidrug‐resistant A. baumannii. These soft, biocompatible hydrogels rapidly reduce bacterial viability within multidrug‐resistant A. baumannii biofilms by more than 99% within one hour and sustain antimicrobial activity over time, while demonstrating safety in both
Jie Han, Mohamed Soliman, Bin Zhang, Dominika Krawiel, Ronan R. McCarthy   +4 more
wiley   +1 more source

Drug-related problems identified in post-discharge medication reviews for patients taking warfarin

, 2011
Objective: To characterise the nature of the drug-related problems with warfarin therapy identified in pharmacist-conducted medication reviews during a collaborative post-discharge warfarin management service, with a focus on potentially serious drug ...
Andrew Stafford (9101424), M. Angley (23430115), Leanne Stafford (17685273), G. Peterson (3954692), J. Hughes (5990414), L. Bereznicki (23322247)   +5 more
core   +1 more source

Intelligent Orthopedics: Machine Learning in Diagnosis of Bone Disease, Implants, and Bone Health Monitoring

Advanced Healthcare Materials, EarlyView.
Efficient recovery from traumatic or degenerative diseases is a great challenge, even after all the advancements in bone and cartilage regeneration. Machine learning (ML) algorithms have presented opportunities to enhance these aspects by accurately analyzing imaging data.
Maryam Kamaei, Hesam Mohammadi, Shamim Golafshan, Mojtaba Alehosseini, Mahsa Mohammadzadeh, Atefeh Golshirazi, Nasim Golafshan, Tatiane Eufrásio‐da‐Silva, Alireza Dolatshahi‐Pirouz, Gorka Orive   +9 more
wiley   +1 more source

Methods for Trends in drug-related hospitalisations in Australia, 2003-2023

The National Illicit Drug Indicators Project provides epidemiological data on trends over time in drug-related harms and forms part of the broader Drug Trends program.
Chrzanowska, Agata ; https://orcid.org/, Degenhardt, Louisa, Sutherland, Rachel ; https://orcid.org/, Man, Nicola, Peacock, Amy   +4 more
core   +1 more source

Overview of drug-related problems (DRPs) at hospitalization, identified by clinical pharmacists, in patients with drug-related hospitalization (DRH) versus non-drug-related hospitalizations (non-DRHs) in the study population (n = 395^a).

, 2019
Overview of drug-related problems (DRPs) at hospitalization, identified by clinical pharmacists, in patients with drug-related hospitalization (DRH) versus non-drug-related hospitalizations (non-DRHs) in the study population (n = 395a).
Kristin Kvernrød (7022792), Marianne Lea (7022786), Espen Molden (3902095), Eva Skovlund (3902086), Morten Mowe (324039), Liv Mathiesen (7022789)   +5 more
core   +1 more source

Mitochondria‐Targeted Nanotherapies in Aging Neurodegenerative Disorders: Emerging Prospects and Clinical Potential

Advanced Healthcare Materials, EarlyView.
Mitochondria‐targeted nanotherapies emerge as a promising strategy for combating aging‐associated neurodegenerative disorders (NDs) by restoring mitochondrial function, reducing oxidative stress, and improving neuronal survival. Recent advances in nanotechnology, therapeutic delivery, and translational research are highlighted, providing insights into ...
Dnyandev G. Gadhave, Ashish B. Jadhav, Nitin B. Waghamode, Shubham Khot, Rajiya Khan, Ravi Hole, Shankar M. Dhobale, Manoj Aswar, Keshav Raj Paudel   +8 more
wiley   +1 more source

Drug interactions with carbamazepine: a case study of influence on anticoagulation treatment with warfarin

Zdravniški Vestnik, 2007
Background: Drug interactions are an important segment of drug related problems. Therefore their evaluation should be an integral component of patient management, especially in elderly patients who often receive multiple medications.
Iztok Grabnar, Igor Locatelli, Darja Herman, Polona Peternel, Mojca Stegnar, Mitja Lainščak, Katja Breskvar, Vita Dolžan, Aleš Mrhar   +8 more
doaj  

Making the Case for Organ‐on‐Chip Platforms in Long‐Acting Therapeutics Development

Advanced Healthcare Materials, EarlyView.
LATs release drug from a tissue‐resident depot over weeks to months, improving adherence, but their development is hampered by preclinical models that cannot reproduce the coupled tissue processes, sustained release, local microenvironment change, interstitial transport, immune and foreign‐body responses, and clearance that govern depot performance in ...
Charlie Gowans, Abdulwahhab Khedr, Panagiotis G. Georgiou, Nehir Arik, Ozlem Sen, Steve P. Rannard, Tom O. McDonald, Christos Tapeinos   +7 more
wiley   +1 more source

Drug-related problems : nurses' role and responsibility

, 2010
Drug-related problems (DRPs) are common and can cause serious adverse effects, even death. The elderly are an exposed group having a higher prevalence of DRPs.
Monica Bergqvist (18407394)
core   +1 more source

An observational study to determine the category and causes of the drug-related problems among geriatric inpatients

National Journal of Physiology, Pharmacy and Pharmacology
Background: Geriatric patients are at a higher risk of drug-related problems (DRPs) because of age-related chronic diseases leading to the use of numerous therapeutic regimens, and pharmacokinetic and pharmacodynamic changes.
Yogita U Naik, Sushma Muraraiah, Rohit Kuppenahalli Lokesha   +2 more
doaj   +1 more source